Skip to content

Comparison of COVID-19 and H1N1 Influenza Pneumonia

Comparison of the Clinical and CT Features Between COVID-19 Pneumonia and H1N1 Influenza Pneumonia in Zhejiang, China

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04933994
Enrollment
483
Registered
2021-06-22
Start date
2017-01-01
Completion date
2020-09-15
Last updated
2021-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, H1N1 Influenza

Keywords

COVID-19, H1N1, Tomography, X-ray computed

Brief summary

To explore the different clinical and CT features distinguishing COVID-19 from H1N1 influenza pneumonia.

Detailed description

COVID-19 pneumonia patients showed less proportions of underlying diseases, fever and respiratory symptoms than those of H1N1 pneumonia patients (p\<0.01). White blood cell count, neutrophilic granulocyte percentage, C-reactive protein, procalcitonin, D-Dimer and lactate dehydrogenase in H1N1 pneumonia patients were higher than those of COVID-19 pneumonia patients (p\<0.05). H1N1 pneumonia were often symmetrically located in the dorsal part of lung inferior lobes, while COVID-19 pneumonia were unsually showed a peripheral but non-specific lobe distributions. Ground glass opacity was more common in COVID-19 pneumonia and consolidation lesions was more common in H1N1 pneumonia (p\<0.01). COVID-19 pneumonia lesions showed a relative clear margin compared with H1N1 pneumonia. Crazy-paving pattern, thickening vessels, reversed halo sign and early fibrotic leisions were more common in COVID-19 pneumonia than H1N1 pneumonia (p\<0.05). Pleural effusion in COVID-19 pneumonia was significantly less common than H1N1 pneumonia (p\<0.01). Compared with H1N1 pneumonia in Zhejiang, China, the clinical manifestations of COVID-19 pneumonia was more concealed with less underlying diseases and slighter respiratory symptoms. The more common CT manifestations of COVID-19 pneumonia included ground glass opacity with a relative clear margin, crazy-paving pattern, thickening vessels, reversed halo sign and early fibrotic leisions, while the less common CT manifestations of COVID-19 pneumonia included consolidation and pleural effusion.

Interventions

DEVICEcomputed Tomography

All cases were detected with computed Tomography

Sponsors

Yueqing People's Hospital of Zhejiang Province
CollaboratorUNKNOWN
Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University
CollaboratorOTHER
Ruian People's Hospital of Zhejiang Province
CollaboratorUNKNOWN
The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
CollaboratorUNKNOWN
First Affiliated Hospital of Zhejiang University
CollaboratorOTHER
Kecheng People's Hospital of Quzhou city, Zhejiang Province
CollaboratorUNKNOWN
Pingyang People's Hospital of Zhejiang Province
CollaboratorUNKNOWN
The First People's Hospital of Yuhang District, Hangzhou, Zhejiang Province
CollaboratorUNKNOWN
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* pneumonia

Exclusion criteria

* no pneumonia

Design outcomes

Primary

MeasureTime frameDescription
Comparison of the clinical and CT features between COVID-19 pneumonia and H1N1 influenza pneumonia in Zhejiang, China1 yearone paper

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026